Factors Driving the Choice of the Best Second-Line Treatment of Advanced NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Factors Driving the Choice of the Best Second-Line Treatment of Advanced NSCLC

Published:2011-01-01 Issue:1 Volume:6 Page:44-51
ISSN:1574-8871
Container-title:Reviews on Recent Clinical Trials
language:en
Short-container-title:RRCT

Author:

Maione Paolo,Rossi Antonio,Anna Bareschino Maria,Claudia Sacco Paola,Schettino Clorinda,Falanga Marzia,Barbato Valentina,Ambrosio Rita,Gridelli Cesare

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of micelles and liposomes as a promising drug delivery system: a review;Drug Delivery and Translational Research;2023-06-06

2. Efficacy and safety of brigatinib in ALK-positive non-small cell lung cancer treatment: A systematic review and meta-analysis;Frontiers in Oncology;2022-11-03

3. A Multidimensional Bayesian Network Meta-Analysis of Chinese Herbal Injections for Treating Non-small Cell Lung Cancer With Gemcitabine and Cisplatin;Frontiers in Pharmacology;2021-09-06

4. Investigation on the Efficiency of Chinese Herbal Injections for Treating Non-small Cell Lung Cancer With Vinorelbine and Cisplatin Based on Multidimensional Bayesian Network Meta-Analysis;Frontiers in Pharmacology;2021-01-29

5. Efficacy and safety of ceritinib in anaplastic lymphoma kinase‐rearranged non‐small cell lung cancer: A systematic review and meta‐analysis;Journal of Clinical Pharmacy and Therapeutics;2020-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP